Li, Ying
Brendel, Matthew
Wu, Ning
Ge, Wenzhen
Zhang, Hao
Rietschel, Petra
Quek, Ruben G. W.
Pouliot, Jean-Francois
Wang, Fei
Harnett, James
Funding for this research was provided by:
Regeneron Pharmaceuticals
Article History
Received: 27 May 2022
Accepted: 8 September 2022
First Online: 21 October 2022
Competing interests
: Ying Li, Ning Wu, Wenzhen Ge, Petra Rietschel, Ruben G. W. Quek, Jean-Francois Pouliot, and James Harnett are employees and shareholders of Regeneron Pharmaceuticals, Inc. Matthew Brendel contributed to the work through a paid internship at Regeneron Pharmaceuticals, Inc. Hao Zhang and Fei Wang have no conflicts of interest to declare.